Teratogen use in women of childbearing potential (intervention study)

The purpose of this study was to quantify the number of women of childbearing potential who are prescribed angiotensin-converting enzyme inhibitor (ACE inhibitor), angiotensin receptor blocker (ARB), or HMG-coenzyme A reductase inhibitor (statin) and to determine the number of documented teratogenic risk discussions (risk documentation) before and after educational interventions.

California Department of Health Services   Follow us on Facebook Follow us on Facebook
EveryWomanCalifornia.org is generously supported by March of Dimes California.
© 2018 Preconception Health Council of California :: Terms :: Disclaimer :: Feedback